Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations

v3.8.0.1
Condensed Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Revenue - related party $ 50 $ 0
Operating expenses:    
Research and development 4,292 706
Research and development - licenses acquired 75 575
General and administrative 2,110 2,025
Total operating expenses 6,477 3,306
Loss from operations (6,427) (3,306)
Other income (expense)    
Interest income 146 90
Interest expense - related party 0 (2)
Total other income (expense) 146 88
Net Loss $ (6,281) $ (3,218)
Net loss per common share outstanding, basic and diluted $ (0.24) $ (0.14)
Weighted average number of common shares outstanding, basic and diluted 26,387,445 22,401,000